The controversy over biomedical conflicts of interest between doctors and companies continued at a Cleveland Clinic conference yesterday. This relationship is necessary, but it shouldn't cause the financial interest of doctors to get in the way of patient care, advised medical experts. While the issue has increased with the rapid pace of medical innovation, Philip Pizzo, Stanford University's medical dean, said the key is to manage the conflicts, not try to eliminate them.